How much funding has Encora Therapeutics raised?

Encora Therapeutics has raised $1.5M in total funding, most recently a Seed round.

Who are Encora Therapeutics's investors?

Encora Therapeutics's investors include Innospark Ventures, Good Growth Capital, The Engine, Endless Frontier Labs, Creative Destruction Lab, MassMEDIC.

When was Encora Therapeutics founded?

Encora Therapeutics was founded in 2018.

Where is Encora Therapeutics headquartered?

Encora Therapeutics is headquartered in Boston, Massachusetts, United States.

What industry is Encora Therapeutics in?

Encora Therapeutics operates in Biotech, Healthcare.

How many employees does Encora Therapeutics have?

Encora Therapeutics has 1-10 employees.

Encora Therapeutics

For your independence

Boston, United States · Founded 2018 · $1.5M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 1–10
Founded: 2018
Business Model: B2B

Website: encoratherapeutics.com
Total Funding: $1.5M
Last Round: $1.5M SeedSep 2020
Rounds: 1

About

Encora Therapeutics is a clinical-stage medtech company developing non-invasive neuromodulation wearable devices to treat neurological movement disorders, particularly essential tremor and Parkinson's disease. Its flagship product, the Encora X1, received FDA 510(k) clearance in February 2026 — following Breakthrough Device Designation in 2021 — and uses proprietary algorithms to analyze a patient's tremors in real time, delivering targeted electrical stimulation to the wrist to disrupt the tremor signal. Founded in 2018 by Daniel Carballo, Allison Davanzo, and Kyle Pina, Encora is based in Boston, Massachusetts and is a resident company of MIT's The Engine deep tech accelerator.

Summary

Encora Therapeutics is a Biotech company based in Boston, United States, founded in 2018. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Sep 2020. Investors include Innospark Ventures, Good Growth Capital and The Engine.